- Company Improves Financial Flexibility -
LAVAL, QC, June 25
/PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today
announced it has amended its debt facility agreement...
This could be huge!How many Shares Issued and Outstanding?Prozac is a does more that $1,000,000,000 a year right?Good find and good luckMarkbody {
background: #FFF;
}
The FDA approval decision date for Labopharm (DDSS)'s Trazodone Contramid Once-Daily drug is coming up in July. If approved, this could become a breakthrough treatment for Depression. To find out...
LAVAL, QC, April 23
/PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS stock news) today
announced the dates and times of its first quarter fiscal 2009 results
...
NEW YORK, Sept. 17
/PRNewswire-FirstCall/ -- Nephros, Inc. (Amex: NEP), a medical device
company focused on developing advanced filtration products for ESRD
therapy...
LAVAL, QC, Sept. 16 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that Mark D'Souza,
Senior Vice-President and Chief Financial...
LAVAL, QC, Nov. 21 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it has received a written response from the U.S. Food and Drug Administration...
Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it has met with the U.S. Food and Drug Administration (FDA) to discuss the matters raised in the Agency's May 30, 2007 Approvable Letter...
